Lunai Bioworks Inc. — Director's Dealing 2021

Mar 12, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Enochian Biosciences Inc (ENOB)
CIK: 0001527728
Period of Report: 2021-03-06

Reporting Person: SAPIRSTEIN JAMES (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-06	Option to Purchase Common Stock	$3.77	A	19894	Acquired	2031-03-06	Common Stock (19894)	Direct

Footnotes

F1: On March 6, 2021, Mr. Sapirstein was granted an option to purchase 19,894 shares of common stock of Enochian Biosciences Inc., said option to vest on March 6, 2022.